Search results
Better Buy: Inovio Pharmaceuticals vs. Novavax
The Motley Fool via AOL· 4 days agoThere are much more attractive stocks in the biotech industry. Should you invest $1,000 in Novavax right now? Before you buy stock in Novavax, consider...
3 Things You Need to Know If You Buy Novavax Today
Motley Fool via Yahoo Finance· 4 days agoNovavax? Novavax stock was a risky buy just a few months ago. But today, the situation looks much brighter. Of course, it will take time for Novavax ...
Why Vaccine Stocks Rallied This Week
Motley Fool via Yahoo Finance· 2 days agoFurthermore, the company just inked a landmark partnership and licensing deal with French pharmaceutical giant Sanofi earlier this month, which agreed to...
Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Barrons.com· 4 days agoFederal officials told Barron’s in March that in the event of a pandemic, they would be able to...
COVID’s New ‘FLiRT’ Variants—What To Know As Experts Fear Summer Surge
Forbes· 4 days agoNew coronavirus variants dubbed “FLiRT” are circulating the world and growing dominant in the U.S.,...
The FLiRT COVID variants: What are they and are they more contagious?
Reuters· 2 days agoThe moniker FLiRT is an acronym for the locations of the mutations the variants share on the virus'...
Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb - Moderna (NASDAQ:MRNA)
Benzinga· 4 days agoAccording to a report from NBC News, experts predict a small rise in COVID-19 cases as a newly...
Free COVID-19 vaccines could be a thing of the past. Experts weigh in.
USA TODAY via Yahoo News· 4 days ago“I hope I'm wrong. But I think that (it's) better to remove barriers to access when we have such...
Could current COVID vaccines protect against future outbreaks? New study offers hope
Orange County Register· 3 days agoA group of researchers had the future in mind when they asked if current COVID-19 vaccines and...
Novavax, Inc. (NASDAQ:NVAX) Given Average Recommendation of “Hold” by Brokerages
ETF DAILY NEWS· 6 days agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) has been given an average recommendation of “Hold” by the five analysts that are presently covering the firm, Marketbeat.com ...
